---
title: "Temsirolimus - Renal cell carcinoma"
sidebar: mydoc_sidebar
permalink: db06287-mesh-d002292-1.html
toc: false 
---


Path ID: `DB06287_MESH_D002292_1`
{% include image.html url="images/db06287-mesh-d002292-1.png" file="db06287-mesh-d002292-1.png" alt="db06287-mesh-d002292-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C401859 | Temsirolimus | Drug |
| InterPro:IPR001179 | FK Binding Protein-12 | GeneFamily |
| UniProt:P42345 | Serine/threonine-protein kinase mTOR | Protein |
| UniProt:Q16665 | Hypoxia-inducible factor-1a (HIF-1a) | Protein |
| UniProt:P15692 | Vascular endothelial growth factor | Protein |
| GO:0001525 | Angiogenesis | BiologicalProcess |
| MESH:D002292 | Renal cell carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Temsirolimus | MOLECULARLY INTERACTS WITH | Fk Binding Protein-12 |
| Fk Binding Protein-12 | DECREASES ACTIVITY OF | Serine/Threonine-Protein Kinase Mtor |
| Serine/Threonine-Protein Kinase Mtor | DECREASES ACTIVITY OF | Hypoxia-Inducible Factor-1A (Hif-1A) |
| Hypoxia-Inducible Factor-1A (Hif-1A) | DECREASES SYNTHESIS OF | Vascular Endothelial Growth Factor |
| Vascular Endothelial Growth Factor | NEGATIVELY REGULATES | Angiogenesis |
| Angiogenesis | CORRELATED WITH | Renal Cell Carcinoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06287#mechanismofaction](https://go.drugbank.com/drugs/DB06287#mechanismofaction)
  - DOI:10.1158/1078-0432.CCR-07-4719

Reference: 
  - [https://go.drugbank.com/drugs/DB06287#mechanismofaction](https://go.drugbank.com/drugs/DB06287#mechanismofaction)
  - DOI:10.1158/1078-0432.CCR-07-4719
